Insmed IncorporatedINSMNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank36
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P36
Within normal range
vs 2Y Ago
-3.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -12.67% |
| Q3 2025 | -6.90% |
| Q2 2025 | 21.56% |
| Q1 2025 | -33.73% |
| Q4 2024 | -8.33% |
| Q3 2024 | -47.14% |
| Q2 2024 | 33.19% |
| Q1 2024 | -40.68% |
| Q4 2023 | 4.04% |
| Q3 2023 | -11.03% |
| Q2 2023 | 16.07% |
| Q1 2023 | -41.84% |
| Q4 2022 | -14.83% |
| Q3 2022 | 12.19% |
| Q2 2022 | 2.72% |
| Q1 2022 | -25.00% |
| Q4 2021 | -11.51% |
| Q3 2021 | -0.00% |
| Q2 2021 | 41.19% |
| Q1 2021 | -92.06% |
| Q4 2020 | -13.85% |
| Q3 2020 | -63.18% |
| Q2 2020 | 37.94% |
| Q1 2020 | -30.47% |
| Q4 2019 | 15.21% |
| Q3 2019 | 34.56% |
| Q2 2019 | -8.37% |
| Q1 2019 | -6.20% |
| Q4 2018 | -6.18% |
| Q3 2018 | -19.26% |
| Q2 2018 | 19.29% |
| Q1 2018 | -41.10% |
| Q4 2017 | -26.11% |
| Q3 2017 | -5.50% |
| Q2 2017 | 1.80% |
| Q1 2017 | 36.32% |
| Q4 2016 | -87.09% |
| Q3 2016 | -9.72% |
| Q2 2016 | 4.37% |
| Q1 2016 | -7.19% |